Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Beclomethasone Dipropionate BAI vs MDI in Healthy Adults
NCT02030457Phase 1Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Dec 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of beclomethasone dipropionate in asthma (3 arms), sponsored by Teva Pharmaceutical Industries Ltd. Primary endpoints: Area under the plasma drug concentration-time curve from time zero to the last measurable concentration at 24 hours and Maximum observed plasma drug concentration at 24 hours. Started Dec 2013; status: completed.
02
Drugs
beclomethasone dipropionate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02030457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02030457.